Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I.

Science. 2005 Jan 21;307(5708):426-30. Retraction in: Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I. Science. 2007 Oct 26;318(5850):565.

2.

[The role of visfatin in the pathophysiology of human].

Skoczylas A.

Wiad Lek. 2009;62(3):190-6. Review. Polish.

PMID:
20229717
3.
4.

Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions.

Adeghate E.

Curr Med Chem. 2008;15(18):1851-62. Review.

PMID:
18691043
5.

Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine.

Sommer G, Garten A, Petzold S, Beck-Sickinger AG, Blüher M, Stumvoll M, Fasshauer M.

Clin Sci (Lond). 2008 Jul;115(1):13-23. doi: 10.1042/CS20070226. Review.

PMID:
19016657
6.

Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity?

Bełtowski J.

Med Sci Monit. 2006 Jun;12(6):RA112-9. Review.

PMID:
16733497
7.

Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.

Tilg H, Moschen AR.

Clin Sci (Lond). 2008 Feb;114(4):275-88. doi: 10.1042/CS20070196. Review.

PMID:
18194136
8.

Visfatin--a review.

Sonoli SS, Shivprasad S, Prasad CV, Patil AB, Desai PB, Somannavar MS.

Eur Rev Med Pharmacol Sci. 2011 Jan;15(1):9-14. Review.

PMID:
21381495
9.

Dysfunctional fat cells, lipotoxicity and type 2 diabetes.

DeFronzo RA.

Int J Clin Pract Suppl. 2004 Oct;(143):9-21. Review.

PMID:
16035392
10.

Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.

Luk T, Malam Z, Marshall JC.

J Leukoc Biol. 2008 Apr;83(4):804-16. doi: 10.1189/jlb.0807581. Review.

PMID:
18252866
11.

Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.

Lorenzo M, Fernández-Veledo S, Vila-Bedmar R, Garcia-Guerra L, De Alvaro C, Nieto-Vazquez I.

J Anim Sci. 2008 Apr;86(14 Suppl):E94-104. Review.

12.

Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.

Schäffler A, Schölmerich J, Büchler C.

Nat Clin Pract Gastroenterol Hepatol. 2005 Jun;2(6):273-80. Review.

PMID:
16265231
13.

Visfatin in pregnancy: proposed mechanism of peptide delivery.

Katwa LC, Seidel ER.

Amino Acids. 2009 Oct;37(4):555-8. doi: 10.1007/s00726-008-0194-7. Review.

PMID:
18953631
14.

Visfatin and its role in obesity development.

Stastny J, Bienertova-Vasku J, Vasku A.

Diabetes Metab Syndr. 2012 Apr-Jun;6(2):120-4. doi: 10.1016/j.dsx.2012.08.011. Review.

PMID:
23153983
15.

Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions.

Pilz S, Mangge H, Obermayer-Pietsch B, März W.

J Endocrinol Invest. 2007 Feb;30(2):138-44. Review.

PMID:
17392604
16.

Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity.

Stofkova A.

Endocr Regul. 2010 Jan;44(1):25-36. Review.

PMID:
20151765
17.

Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances.

Matsuzawa Y, Funahashi T, Nakamura T.

Ann N Y Acad Sci. 1999 Nov 18;892:146-54. Review.

PMID:
10842660
18.

Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders.

Moschen AR, Gerner RR, Tilg H.

Curr Pharm Des. 2010 Jun;16(17):1913-20. Review.

PMID:
20370672
19.

Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling.

Johnston AM, Pirola L, Van Obberghen E.

FEBS Lett. 2003 Jul 3;546(1):32-6. Review.

20.

Nampt and its potential role in inflammation and type 2 diabetes.

Garten A, Petzold S, Schuster S, Körner A, Kratzsch J, Kiess W.

Handb Exp Pharmacol. 2011;(203):147-64. doi: 10.1007/978-3-642-17214-4_7. Review.

PMID:
21484571

Supplemental Content

Support Center